Abel Hall, LLC Alx Oncology Holdings Inc Transaction History
Abel Hall, LLC
- $248 Billion
- Q3 2025
A detailed history of Abel Hall, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Abel Hall, LLC holds 12,598 shares of ALXO stock, worth $16,125. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,598
Previous 15,209
17.17%
Holding current value
$16,125
Previous $6.31 Million
265.18%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALXO
# of Institutions
69Shares Held
30.3MCall Options Held
173KPut Options Held
0-
Ven Bio Partners LLC San Francisco, CA9.7MShares$12.4 Million12.08% of portfolio
-
Redmile Group, LLC San Francisco, CA3.33MShares$4.27 Million0.67% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$3.44 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.62MShares$3.36 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA2.54MShares$3.25 Million2.19% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $52.2M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...